February 04, 2025

Some bacteria in the mouth may play a role in memory loss and dementia

Scientists are examining the link between bacteria in the mouth and neurodegenerative diseases such as dementia.

  • New research suggests that the bacteria living in our mouths may influence cognitive function as we age.
  • Several bacterial species have been identified as potentially more harmful than others, and some of these microbes may play a role in memory loss and dementia.
  • Scientists are now exploring how oral health, along with diet and certain prebiotics, might help slow cognitive decline and protect against conditions like Alzheimer’s disease.

As people age, their memory and thinking skills naturally decline. Approximately 15% of older adults experience mild cognitive impairment, a major risk factor for dementia and other forms of dementia such as Alzheimer’s disease.

Since cognitive decline and dementia are growing public health concerns, scientists are working to better understand the risk factors and find ways to reduce them. One emerging area of research suggests that oral health may play a role in brain health.

Now, a new study suggests that the bacteria living in the mouth may influence cognitive function as people age, with some harmful bacteria possibly contributing to the development of dementia and Alzheimer’s disease.

The findings were published in the journal PNAS Nexus.

Diet affects the oral microbiome

In this study, researchers analyzed the oral microbiome of 115 individuals, including 55 with mild cognitive impairment.

Some participants carried the apolipoprotein E4 (APOE4) allele, which is linked to an increased risk of cognitive decline and Alzheimer’s disease.

Within the mild cognitive impairment group, a higher abundance of Neisseria bacteria was associated with better executive function and visual attention.

Among healthy individuals, Neisseria was linked to stronger working memory.

The presence of Porphyromonas bacteria was a key predictor of mild cognitive impairment, while Prevotella intermedia was linked to APOE4-carrier status.

The researchers noted that diet influences the oral microbiome, with nitrate-rich diets — such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet — supporting bacteria that are beneficial for cognitive function.

Diet supports bacteria that are good for cognitive function

James Giordano, Ph.D., Pellegrino Center Professor, Departments of Neurology and Biochemistry at the Georgetown University Medical Center in Washington, DC, not involved in the study, spoke to Medical News Today.

“This study was well-conceived and -conducted, and built upon extant research that has fortified a link both between the gut microbiome and brain function, and the role of the oral microbiome and health,” Giordano explained.

“This study importantly demonstrated that maintenance of the oral microbiome can be an important factor to the overall integrity of (oral and GI) microbiome-brain functional reciprocity and health, and that key flora of the oral microbiome are particularly influential in maintaining this functional integrity.”
— James Giordano, Ph.D.

“Specifically, the authors demonstrated that the presence of particular species of oral microbiome flora appear to be instrumental to circulatory and cerebral production of the gaseous neuromodulating chemical nitric oxide (NO),” Giordano said.

“NO has been shown to affect cerebrovascular tone and to regulate the intracellular signalling processes crucial for neural functions, inclusive of those operative in cognitive processing. NO has also been shown to exert protective effects against neuroinflammatory processes operative in loss of neural function that is contributory to cognitive impairment,” he continued.

Oral Bacteria, Nitric Oxide, And Neuroinflammation

“Thus, the authors provide evidence that specific flora of the oral microbiome are important for the production of NO and the maintenance of NO-dependent neural functioning, which may play a role in sustaining cognitive capabilities. [O]ther oral microbiome species appear to both inhibit normal flourishing of beneficial flora, thereby reducing these beneficial effects, and these pathogenic species may directly impact brain health and function by contributing to chemical processes of neuroinflammation.”— James Giordano, Ph.D.

Poor oral health, gum disease may be implicated in dementia

Gum disease, or periodontitis, has been linked to poorer cognitive function. Researchers believe this connection may be due to the presence of harmful bacteria in the mouth, such as Porphyromonas gingivalis, Treponema denticola, and Prevotella intermedia.

These bacteria contribute to gum disease by causing inflammation and damage, but they may also affect the brain in ways that increase the risk of cognitive decline.

One way oral bacteria may influence brain health is by entering the bloodstream when there is damage in the mouth, such as bleeding gums.

Once in the blood, these bacteria can travel to the brain, especially in people with Alzheimer’s, as the blood-brain barrier — the protective shield that normally keeps harmful substances out — becomes more porous in the disease.

In fact, bacteria linked to oral infections have been found in the brain fluid of people with brain infections, and P. gingivalis has been detected in the brains of Alzheimer’s patients.

Oral bacteria may also influence inflammatory pathways

Another possible way that oral bacteria could contribute to cognitive decline is through their effect on the immune system.

These bacteria in the mouth can damage its protective barrier, making it easier for harmful substances to get into the bloodstream.

This can lead to inflammation that spreads throughout the body.

Long-term inflammation has been connected to brain aging and memory problems, meaning these bacteria might affect more than just oral health.

These findings highlight the importance of maintaining good oral hygiene, not just for healthy teeth and gums but also for long-term brain health.

How to support the oral microbiome

Giordano pointed out that “these findings strengthen evidence that oral health and maintenance of key species of the oral microbiome are instrumental for brain health.”

“[T]hese findings suggest that re-establishment or supplementation of a dominant population of particular species of oral microflora may be beneficial to mitigating neuroinflammation and sustaining neuro-cognitive functions,” he said.

Jennifer Bramen, PhD, senior research scientist and director of neuroimaging at the Pacific Neuroscience Institute in Santa Monica, CA, who was also not involved in the study, explained that incorporating nitrate-rich foods into your diet can benefit the oral microbiome.

“This study suggests that incorporating nitrate-rich foods like vegetables into one’s diet can benefit the oral microbiome by promoting bacteria associated with better oral and cognitive health outcomes while suppressing those associated with disease.”— Jennifer Bramen, PhD

In conclusion, Giordano added that “this study offers promise both for sampling the flora of the oral microbiome as putative predictive biomarkers of brain health, and fortifying the beneficial species of oral microbiome flora to maintain brain health and function.”

https://www.medicalnewstoday.com/articles/some-bacteria-mouth-microbiome-may-play-role-memory-loss-dementia

Australian research finds no link between mobile phones and various cancers

Australian scientists have conducted groundbreaking research examining potential links between mobile phone use and cancer. The study, commissioned by the World Health Organization, found no significant association between radio wave exposure and various cancer types. Lead researcher Ken Karipidis noted some uncertainty due to limited evidence, but the findings provide important insights into wireless technology's health impacts. This research contributes to ongoing global efforts to understand potential long-term health effects of mobile phone radiation.

"This is because there is not as much evidence on the association between these cancers and exposure to radio waves from wireless technology" - Ken Karipidis, ARPANSA

Canberra, Feb 4: Research led by Australia's nuclear and radiation safety agency has found no link between mobile phone use and various cancers.

Key Points

1 Australian research examines mobile phone radiation's potential cancer risks

2 WHO-commissioned study explores wireless technology health impacts

3 No definitive link found between radio waves and cancer types

 

The research, commissioned by the World Health Organization (WHO) and published on Tuesday, found no association between radio wave exposure from mobile phones and various cancers, including leukaemia, lymphoma and cancers of the thyroid and oral cavity.

It was the second WHO-commissioned systematic review undertaken by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), reports Xinhua news agency.

The first review, published in September 2024, explored the association between mobile phone use and brain and other head cancers and found no link.

Ken Karipidis, the lead author of both studies and assistant director of Health Impact Assessment at ARPANSA, said the new research assessed all available evidence on the association between mobile phones, mobile phone towers and cancers.

He said that the researchers found no link between radio wave exposure and the various cancers but that the team cannot be as certain of the results compared to the review on brain cancers.

"This is because there is not as much evidence on the association between these cancers and exposure to radio waves from wireless technology," Karipidis said.

Rohan Mate, an ARPANSA scientist who contributed to the study, said the findings would "add to the body of knowledge to inform the public about wireless technology and cancer".

The two systematic reviews will inform an updated assessment of the health effects of radio wave exposure currently being prepared by the WHO.

According to the WHO, Cancer is a large group of diseases that can start in almost any organ or tissue of the body when abnormal cells grow uncontrollably, go beyond their usual boundaries to invade adjoining parts of the body and/or spread to other organs. The latter process is called metastasising and is a major cause of death from cancer. A neoplasm and malignant tumour are other common names for cancer.

Cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or 1 in 6 deaths, in 2018. Lung, prostate, colorectal, stomach and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical and thyroid cancer are the most common among women.

The cancer burden continues to grow globally, exerting tremendous physical, emotional and financial strain on individuals, families, communities and health systems. Many health systems in low- and middle-income countries are least prepared to manage this burden, and large numbers of cancer patients globally do not have access to timely quality diagnosis and treatment.

February 03, 2025

Women with twins 2x more at higher risk of heart disease: Study

A fascinating new study reveals that women who give birth to twins are twice as likely to experience heart-related complications in the first year after delivery. Researchers from Rutgers University discovered that twin pregnancies significantly strain the maternal heart, with increased risks of hospitalization for cardiovascular issues. The research highlights the importance of monitoring mothers with twin pregnancies, especially those with pre-existing blood pressure conditions. Healthcare providers are now urged to conduct careful follow-ups for women who undergo twin pregnancies, particularly those with advanced fertility treatments.

"The maternal heart works harder for twin pregnancies" - Dr. Ruby Lin, Rutgers University

New Delhi, Feb 3: Women who give birth to twin babies are two times more at risk of facing a heart problem than those with singleton births, according to a study on Monday.

Key Points

1Twin pregnancies increase cardiac hospitalization risk within one year

2Blood pressure complications further elevate cardiovascular dangers

3Research analyzed 36 million US hospital deliveries from 2010-2020

The research, published in the European Heart Journal, showed that the mother of twins is at higher risk of hospitalisation due to heart disease a year after birth.

Notably, the risk is even higher in those who had a high blood pressure condition during pregnancy, also known as preeclampsia.

The study, led by researchers from Rutgers University in the US, comes as "the rate of twin pregnancies worldwide has risen in recent decades, driven by fertility treatments and older maternal ages".

"The maternal heart works harder for twin pregnancies than for singleton pregnancies, and it takes weeks for the maternal heart to return to its pre-pregnancy state," said lead author Dr. Ruby Lin, a maternal-foetal medicine fellow at Rutgers Robert Wood Johnson Medical School.

"People with twin pregnancies should be aware of the short-term increase in cardiovascular disease complications in the first year after birth, even if they had a pregnancy that was not complicated by high blood pressure conditions, such as pre-eclampsia," she added.

The study analysed data on 36 million hospital deliveries in the US from 2010 to 2020.

The results showed a higher proportion of readmissions for cardiovascular disease within a year of giving birth in women with twins (1,105.4 per 100,000 deliveries) than those with singleton pregnancies (734.1 per 100,000 deliveries).

Compared to singleton pregnancies with normal blood pressure, people with twins with normal blood pressure were around twice as likely to be hospitalised with cardiovascular disease.

For those with twins with high blood pressure during pregnancy, the risk was more than eight times higher. However, one year after birth, deaths from any cause, including heart disease, were higher among patients with singleton pregnancies who had high blood pressure conditions compared to patients with twins with high blood pressure conditions, the study showed.

This suggests that the risk to mothers of twins decreases in the longer term, while the mothers of singletons may have other pre-existing cardiovascular risk factors.

Lin said that patients undergoing fertility treatments, especially those with advanced age, obesity, diabetes, high blood pressure, or heart disease, should be advised that twin pregnancies may increase complications related to heart disease in the short term.

She also urged healthcare providers to continue follow-up for up to a year after birth for high-risk pregnancies.

https://www.newkerala.com/news/o/women-twins-2x-higher-risk-heart-disease-study-758

85 pc increase in cancer cases, deaths expected by 2050 in SE Asia: WHO

In 2022, the WHO South-East Asia Region had 2.4 million new cases of cancer, including 56,000 children, and 1.5 million deaths

South-East Asia region is expected to witness an 85 per cent increase in the number of new Cancer cases and deaths, said the World Health Organization (WHO) on Monday, ahead of World Cancer Day.

Each year, February 4 is commemorated as World Cancer Day.

“The theme this year United by Unique is a reminder of the collective commitment against cancer,” said Saima Wazed, Regional Director for WHO South-East Asia.


“WHO acknowledges every patient's unique experiences and the value of people-centered care delivered jointly by healthcare providers, families, friends, and community,” she added.

 

In 2022, the WHO South-East Asia Region had 2.4 million new cases of cancer, including 56,000 children, and 1.5 million deaths.

 

 “Among all the WHO regions, our Region had the highest number of cancers of lips and oral cavity, uterine cervix, and childhood cancers. It is estimated that by 2050, there will be an 85 per cent increase in the number of new cases and deaths in the Region,” said Wazed.

 

She also noted the progress made in countries in the Region in the last few years. This includes a reduction in tobacco consumption.

 

“The Region has seen the fastest rate of decline in tobacco use which is a major risk factor for several high burden cancers,” Wazed said.

 

Wazed said six countries have dedicated national plans for cancer control, and two countries have included cancer as part of the national NCD plan to strategically guide cancer prevention and control activities.

 

Eight countries have introduced nationwide Human Papillomavirus (HPV) vaccination.

 

The Regional Director said that 10 countries are implementing global initiatives for childhood cancer and seven countries have operational population-based cancer registries. In 10 countries, tertiary-level cancer care is generally available, reaching 50 per cent or more patients in need.

 

However, some persisting challenges include scattered responses to cancer control. National cancer control programmes and plans are not fully aligned with evidence or best practices resulting in their ineffective implementation.

 

Policies and guidance on control of cancer-causing agents prevalent in the Region, such as areca nut, are lacking.

 

Existing cancer prevention policies and programmes are not fully implemented, leading to millions of avoidable cases, Wazed said. Late diagnosis and lack of national capacities to manage the increasing cancer burden also hinder cancer control.


https://www.tribuneindia.com/news/health/85-pc-increase-in-cancer-cases-deaths-expected-by-2050-in-se-asia-who/

Dangerously Underdiagnosed: The Silent Killer Affecting 30 Million Americans and Counting

COPD, part of the chronic lower respiratory disease category, is now the sixth leading cause of death in the U.S. Awareness remains low, even though millions unknowingly suffer from it. The CDC reports a 3.5% increase in deaths, emphasizing the need for action.

Despite affecting over 30 million Americans, COPD remains dangerously underdiagnosed.

As a leading cause of death, this chronic respiratory disease continues to claim lives, yet awareness and early diagnosis efforts lag behind. With death rates rising and women disproportionately affected, experts stress the urgent need for education and prevention.

Chronic Respiratory Diseases: A Leading Cause of Death

Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). The CDC’s National Center for Health Statistics confirmed this ranking in its final “Deaths: Leading Causes for 2022” report.

COPD includes conditions like chronic bronchitis and emphysema and can develop due to genetics or long-term exposure to irritants such as smoke and pollution. Common symptoms include breathlessness, fatigue, and a persistent cough.

Millions Affected, Many Unaware

More than 30 million Americans have COPD, yet about half remain undiagnosed. Awareness of symptoms, risk factors, and disease management is still low. On a global scale, COPD ranks as the fourth leading cause of death, according to 2021 data from the World Health Organization.

“COPD affects millions of people in the United States and worldwide. However, despite being a leading cause of death, many are unaware of the disease and its symptoms,” said Jean Wright, M.D., MBA, CEO of the COPD Foundation. “We must continue to increase awareness of COPD and to educate people about the disease’s symptoms and the importance of early diagnosis, helping people live longer, healthier lives.”

Rising Deaths and Gender Disparities

According to the report, the number of deaths from chronic lower respiratory diseases increased by 3.5% in 2022. Chronic lower respiratory diseases were the sixth leading cause of death for both men and women; however, the burden of death was higher for women (5.0%) than men (4.0%).

The ten leading causes of death in the United States in 2022 were:

1.     Diseases of the heart.

2.     Malignant neoplasms.

3.     Accidents (unintentional injuries).

4.     COVID-19.

5.     Cerebrovascular diseases.

6.     Chronic lower respiratory diseases.

7.     Alzheimer’s disease.

8.     Diabetes mellitus.

9.     Nephritis, nephrotic syndrome and nephrosis.

10.  Chronic liver disease and cirrhosis.

The report data uses information from all death certificates filed in the United States in 2022. Cause of death statistics are based on the underlying cause of death and are classified by the International Classification of Diseases, 10th Revision.

https://scitechdaily.com/dangerously-underdiagnosed-the-silent-killer-affecting-30-million-americans-and-counting/

Revolutionary Biology Discovery Combines DNA and RNA To Fight Cancer

Recent research reveals that DNA and RNA epigenetics, previously studied as independent systems, actually function as a complementary regulatory network. This dual mechanism enables precise gene activation, critical for cellular development and function. Published in Cell, the study uncovers a novel mode of gene regulation and its role in diseases like cancer, paving the way for personalized therapies using “epigenetic drugs” that target both DNA and RNA.

A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell function and development, with implications for advanced cancer therapies.

Our genes carry the complete set of instructions necessary for our body to function, but their expression must be carefully regulated to ensure that each cell fulfills its specific role efficiently. This is where DNA and RNA epigenetics come into play: a collection of mechanisms that act like “markers” on genes, controlling their activity without altering the underlying DNA or RNA sequences.

Traditionally, DNA and RNA epigenetics have been studied as separate systems. These two mechanisms were thought to operate independently, each contributing to different stages of the gene regulation process.

Perhaps that was a mistake.

In a publication in the journal Cell, researchers led by François Fuks, the Laboratory of Cancer Epigenetics, ULB Faculty of Medicine, ULB-Cancer Research Center, and Jules Bordet Institute, H.U.B. reveal that in fact, DNA and RNA epigenetics could be more interconnected than previously thought. The researchers have discovered that they form a complementary regulation system, in which DNA epigenetics organizes the available genes and RNA epigenetics dynamically adjusts their use.

How Dual Epigenetic Markers Work

In concrete terms, the study demonstrates that when these two markers are added jointly to a gene, they enable a more effective activation of that gene. On the other hand, if one of these processes is not working correctly, the gene’s activity diminishes. François Fuks and his colleagues have shown that this mechanism is particularly important in key stages like cells’ development or their specialization into different types, for example in embryonic stem cells.

This combination offers incredibly precise regulation of gene activity, essential to the development of organisms and the harmonious functioning of cells.

Implications for Biology and Medicine

Published on January 17 in the journal Cell, this fundamental breakthrough sheds light on a completely new mode of gene control, opening up unprecedented perspectives in biology. It helps us to gain a better understanding of how our cells work and how disruptions to these mechanisms can cause diseases like cancer.

This discovery could also lead to advances in cancer treatments. Making use of this complementary regulation system raises the prospect of developing therapies based on “epigenetic drugs” that target DNA and RNA at the same time. The scientists hope to be able to develop more precise and personalized treatments, capable of targeting these regulation mechanisms to restore balance to diseased cells in cancer patients.

Prof. Fuks’ team is already carrying out research connected directly to the work published in Cell. These ongoing studies aim to demonstrate the clinical usefulness of their discovery, by exploring the potential of epigenetic therapies acting on DNA and RNA.

Reference: “Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation” by Giuseppe Quarto, Andrea Li Greci, Martin Bizet, Audrey Penning, Irina Primac, Frédéric Murisier, Liliana Garcia-Martinez, Rodrigo L. Borges, Qingzeng Gao, Pradeep K.R. Cingaram, Emilie Calonne, Bouchra Hassabi, Céline Hubert, Adèle Herpoel, Pascale Putmans, Frédérique Mies, Jérôme Martin, Louis Van der Linden, Gaurav Dube, Pankaj Kumar, Romuald Soin, Abhay Kumar, Anurag Misra, Jie Lan, Morgane Paque, Yogesh K. Gupta, Arnaud Blomme, Pierre Close, Pierre-Olivier Estève, Elizabeth A. Caine, Kristin M. Riching, Cyril Gueydan, Danette L. Daniels, Sriharsa Pradhan, Ramin Shiekhattar, Yael David, Lluis Morey, Jana Jeschke, Rachel Deplus, Evelyne Collignon and François Fuks, 17 January 2025, Cell.
DOI: 10.1016/j.cell.2024.12.009

The work is supported by the F.N.R.S, Télévie, Welbio, the Belgian Foundation Against Cancer, an ARC (Action de Recherche Concertée – Collective Research Initiative), the ULB Foundation and Wallonia.

https://scitechdaily.com/revolutionary-biology-discovery-combines-dna-and-rna-to-fight-cancer/

New MRI Study Reveals How Cannabis Alters Brain Activity and Weakens Memory

Researchers found that heavy cannabis use reduces brain activity during working memory tasks, leading to cognitive struggles. Brain scans showed changes in regions responsible for memory and decision-making. While abstaining may help, more research is needed to understand long-term effects. Credit: SciTechDaily.com

A massive new study sheds light on how cannabis affects the brain, particularly during cognitive tasks.

Researchers analyzed over 1,000 young adults and found that both heavy lifetime use and recent cannabis consumption significantly reduced brain activity during working memory tasks. This impairment was linked to worse performance on tasks requiring focus, problem-solving, and instruction-following. Brain imaging revealed that key regions responsible for decision-making and attention were affected.

Cannabis Use and Brain Function: A Groundbreaking Study

A new study published in JAMA Network Open examines how both recent and long-term cannabis use affects brain function during cognitive tasks.

As the largest study of its kind, researchers analyzed over 1,000 young adults aged 22 to 36 using brain imaging technology. They found that 63% of heavy lifetime cannabis users showed reduced brain activity during a working memory task, with a similar impact seen in 68% of recent users.

Reduced Brain Activity and Working Memory Impairment

This decrease in brain activity was linked to poorer performance on working memory — a crucial function that helps people retain and use information for tasks. For instance, working memory enables someone to follow instructions, mentally visualize concepts, or solve problems like math equations.

“As cannabis use continues to grow globally, studying its effects on human health has become increasingly important. By doing so, we can provide a well-rounded understanding of both the benefits and risks of cannabis use, empowering people to make informed decisions and fully comprehend the potential consequences,” said the study’s first author Joshua Gowin, PhD, assistant professor of radiology at the University of Colorado School of Medicine on the University of Colorado Anschutz Medical Campus.

In the study, heavy users are considered young adults who’ve used cannabis more than 1000 times over their lifetime. Whereas, using 10 to 999 times was considered a moderate user, and less than 10 times was considered a nonuser.

MRI Scans Reveal Cannabis’ Impact on Brain Function

The researchers studied the neural response of participants during a magnetic resonance imaging (MRI) session and gave them seven cognitive tasks to complete. The tasks tested working memory, reward, emotion, language, motor skills – such as tapping a finger to map brain control, relational assessment and theory of mind.

The researchers found that cannabis had a statistically significant effect on brain function during working memory tasks, meaning the observed impact is very unlikely to be due to random chance. This effect was seen in both recent and lifetime cannabis users. The impact was less significant for the other tasks.

“We applied the highest standards to our research, setting rigorous thresholds for statistical significance across all seven cognitive function tests. To minimize the risk of false positives, we employed false discovery rate (FDR) correction. While some of the other tasks indicated potential cognitive impairment, only the working memory task showed a statistically significant impact,” adds Gowin.

Key Brain Regions Affected by Heavy Cannabis Use

During working memory tasks, the researchers found heavy cannabis use appeared to reduce brain activity in certain areas of the brain (dorsolateral prefrontal cortex, dorsomedial prefrontal cortex, and anterior insula). These regions of the brain are involved in important cognitive functions such as decision-making, memory, attention, and emotional processing.

However, Gowin mentions their research also suggests that abstaining from using cannabis before doing a cognitive task could help to improve performance. “People need to be aware of their relationship with cannabis since abstaining cold turkey could disrupt their cognition as well. For example, heavy users may need to be more cautious,” Gowin says.

Unanswered Questions: The Future of Cannabis Research

He adds, “There are a lot of questions we still need answers to regarding how cannabis impacts the brain. Large, long-term studies are needed next to understand whether cannabis use directly changes brain function, how long these effects last, and the impact on different age groups.”

Study offers new hope against chronic pain for dialysis patients

A groundbreaking study has discovered a promising new approach to managing chronic pain for dialysis patients through pain coping skills training. Researchers found that specialized coaching sessions can significantly reduce patient suffering and improve overall quality of life. The innovative method focuses on psychological techniques like cognitive behavioral therapy and mindfulness, offering an alternative to traditional opioid treatments. With 643 participants across multiple medical centers, this research represents a major step forward in addressing the complex pain challenges faced by dialysis patients.

"It is great to see these results in press and offer alternatives other than opioids to our patients on dialysis" - Dr. Mark Unruh

New Mexico, February 1: People receiving haemodialysis for kidney failure frequently feel chronic pain associated with their disease, which can be difficult to manage with opioid medication and other traditional treatments.

Key Points

1 Specialized coaching helps dialysis patients manage chronic pain effectively

2 Psychological interventions provide alternative to opioid treatments

3 Study demonstrates modest improvements in daily activity limitations

4 Targeted approach addresses pain-related anxiety and stress

 

A new study finds that offering these patients pain coping skills training (PCST) significantly reduced their suffering and improved their quality of life.

Twenty-two New Mexicans - many of them Native American - participated in UNM's arm of the study, said Mark Unruh, MD, Chair, UNM Department of Internal Medicine

"This is particularly important for these patients since the therapeutic choices for pain management are limited and the use of opioids has been shown to be associated with poor outcomes in this group."

The randomized controlled study enrolled 643 participants from 16 medical centers and 103 dialysis clinics in The HOPE Consortium, an ongoing multi-site study exploring new treatments for dialysis patients.

"New Mexico played a large role in the trial," he said. "We served as the primary outcomes measurement core and New Mexico had a supplement to recruit from rural clinics with a focus on our underrepresented populations."

Multiple factors likely contribute to dialysis-related pain. Patients tend to be older and living with arthritis, diabetes, peripheral neuropathy and back pain, he said.

"Dialysis by itself may contribute, either directly or indirectly, like having uremic toxins in your bloodstream," Unruh said. "The process of going to dialysis and having a needle stuck in your arm may be challenging for some people to deal with."

Doctors face challenges in treating dialysis-related pain because patients have kidney failure. "We are kind of loathe to use nonsteroidal anti-inflammatory agents, and in general we avoid opioids," he said. "Certain opioids are better than others, but a lot of them are cleared in part from the kidneys. You kind of have your hands tied."

Half of the study participants were randomly assigned to receive the PCST intervention, while the other was assigned to receive usual care. The PCST consisted of 45-minute coaching sessions by counselors delivered via phone or video for 12 weeks, followed by an additional 12 weeks of daily automated interactive voice response sessions to monitor the participants' progress.

The content included modules addressing pain-related anxiety, stress and sleep difficulties along with CBT, mindfulness, pain education, experiential training, with the overarching goal of enhancing self-efficacy for applying the acquired coping skills.

"It's like a recipe with 12 components," Unruh said. "You talk about strategies, and focus on reframing and limiting catastrophizing. You'll do some mindfulness meditation, and then you'll talk about addressing, anxiety and depression and strategies to prevent backsliding."

The study found that patients who underwent the PCST intervention showed modest improvements in the extent to which pain interfered with their daily activities, he said. "The relevance would be that, if I'm seeing someone in a clinic who has chronic pain, rather than prescribing an opioid, I could refer them to a psychologist who practices CBT, and they could kind of adopt it."

The study is an example of how research can lead to improvements in clinical care, Unruh said. "It is great to see these results in press and offer alternatives other than opioids to our patients on dialysis for treatment of chronic pain."

New research identified rare type immune cells for response against Cancer: Study

Imagine a breakthrough that could change how we fight chronic diseases like cancer - researchers have discovered a special type of immune cell that doesn't get tired! These unique "stem-like T cells" have an incredible ability to resist exhaustion, thanks to a protein called ID3. The study, conducted by Melbourne's top research institutes, suggests this could lead to more effective and long-lasting treatments. It's like finding a superhero in our immune system that never gives up fighting.

"ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time" - Catarina Gago da Graca

Melbourne, February 3: The researchers have identified a rare type of immune cell, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses against cancer and other chronic infections.

Key Points

1 Rare stem-like T cells identified with extraordinary disease-fighting capabilities

2 ID3 protein enables unique self-renewal and immune resilience

3 Research could transform cancer immunotherapy and treatment strategies

Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders - T cells - lose their ability to function effectively.

The research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Centre (Peter Mac), revealed that the endurance of stem-like T cells is fuelled by a protein called ID3 and is expressed by a gene of the same name.

As per the Study, these ID3+ T cells have a unique ability to self-renew and resist exhaustion, giving them the power to sustain immune responses far longer than other T cells that don't express ID3 against chronic diseases.

The study is published in Science Immunology. The University of Melbourne's Catarina Gago da Graca, PhD Candidate at the Doherty Institute, said the research highlights how ID3+ T cells hold the key to overcoming one of the biggest challenges in treating chronic diseases--immune exhaustion.

"ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time, making them particularly effective in the face of chronic infections or cancer," said co-first author Gago da Graca.

The research also found that certain signals in the body could increase the number of ID3+ T cells, paving the way for improved treatments like CAR T cell therapy.

Professor Ricky Johnstone, Executive Director of Cancer Research at Peter Mac and co-lead author of the study, said enhancing ID3 activity could strengthen the endurance of these cells, making therapies more effective and long-lasting.

"We discovered that ID3+ T cell formation could be promoted by specific inflammatory cues, potentially offering new strategies to boost the number of immune cells that excel at fighting cancer in patients," said Professor Johnstone.

"This could lead to better treatments for cancer patients and improve clinical immunotherapy outcomes." he added.

The University of Melbourne's Dr Daniel Utzschneider, Laboratory Head at the Doherty Institute, said the findings could lead to advancements in immunotherapy treatments and the development of vaccines that provide long-lasting protection.

This research is the result of a collaborative effort between the Doherty Institute, Peter Mac, La Trobe University, Northwestern University (USA), the Olivia Newton-John Cancer Research Institute, the University of Birmingham (UK) and the University of Melbourne.

Daycare cancer centres in every district in India a timely initiative

The Indian government has unveiled an ambitious plan to establish daycare cancer centres in every district over the next three years. With cancer cases expected to rise significantly, this initiative aims to improve treatment accessibility, especially in remote areas. The budget also includes provisions for adding life-saving drugs and expanding medical education to support healthcare infrastructure. These strategic moves signal a comprehensive approach to addressing India's growing healthcare challenges.

"The establishment of daycare cancer centres in all district hospitals is a critical move towards enhancing accessibility to specialised treatment." - Garima Malhotra, Praxis Global Alliance

New Delhi, Feb 2: The Union Budget's plan to establish daycare cancer centres in every district over the next three years is a timely initiative, experts said on Sunday.

Key Points

1 Cancer incidence rising with 27.7% expected increase by 2025

2 Government planning 200 daycare cancer centres by 2025-26

3 36 life-saving drugs to be exempted from customs duty

4 Medical education expansion with 10,000 additional seats

Cancer incidence in India is rising, with cases expected to increase by 27.7 per cent from 2015 to 2025.

According to the 'National Cancer Registry Programme Report' 2020, one in nine people is likely to develop cancer in their lifetime.

The Budget move "aims to improve access to cancer treatment and support, particularly in remote areas, bridging a critical gap in healthcare services," said Ashok Varma, Partner, Grant Thornton Bharat.

The Government will facilitate the setting up of daycare cancer centres and 200 such centres will be established in 2025-26.

Moreover, the Budget announced 36 life-saving drugs and medicines (mainly for cancer and rare diseases) to be added to the list of medicines that are fully exempt from basic customs duty (BCD). Another six life-saving medicines are to be added to the list, which would attract concessional customs duty of 5 per cent.

Garima Malhotra, Associate Partner, Healthcare and Lifesciences at Praxis Global Alliance, said that the expansion of medical education with 10,000 additional seats and the plan to add 75,000 seats over the next five years will address the shortage of healthcare professionals.

"The establishment of daycare cancer centres in all district hospitals is a critical move towards enhancing accessibility to specialised treatment. These measures, along with continued investment in public health infrastructure, will improve healthcare access and affordability, fostering a healthier India," she mentioned.

The Government's push for improved access to life-saving medicines through the addition of 36 drugs to the exempted list and enhanced support for rare disease treatments is a welcome move.

The rationalisation of customs tariffs for industrial goods, including incentives for domestic pharmaceutical manufacturing, will further boost India's position as the 'Pharmacy of the World.'

The emphasis on R&D with a Rs 20,000 crore investment in private-sector-led innovation will also accelerate drug discovery and biotech advancements, said experts.

Research unlocks key to long-lasting immune response in cancer

Researchers have uncovered an incredible breakthrough in understanding how certain T cells can maintain powerful immune responses over time. By identifying a unique protein called ID3, scientists found that some immune cells can resist exhaustion and continue fighting chronic diseases effectively. This discovery could revolutionize treatments for cancer and persistent infections by potentially enhancing immune cell durability. The research offers a promising new approach to strengthening the body's natural defense mechanisms and improving long-term patient outcomes.

"ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time" - Catarina Gago da Graca

Melbourne, February 1: Prolonged illnesses, such as cancer and persistent infections, can fatigue the immune system, causing its frontline defenders, T cells, to lose their ability to act efficiently.

Key Points

1 Stem-like T cells maintain powerful long-term immune responses

2 ID3 protein enables T cells to self-renew and resist exhaustion

3 Research could transform immunotherapy and chronic disease treatment

4 Specific inflammatory signals can promote immune cell formation

The Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Centre (Peter Mac) have discovered a unique type of immune cell known as stem-like T cells, which is essential for maintaining potent, long-term immune responses.

The study revealed that the endurance of these stem-like T cells is fuelled by a protein called ID3, expressed by a gene of the same name. These ID3+ T cells have a unique ability to self-renew and resist exhaustion, giving them the power to sustain immune responses far longer than other T cells that don't express ID3.

The University of Melbourne's Catarina Gago da Graca, PhD Candidate at the Doherty Institute, said the research highlights how ID3+ T cells hold the key to overcoming one of the biggest challenges in treating chronic diseases--immune exhaustion.

"ID3+ T cells have the remarkable ability to resist burnout and maintain a powerful immune response over time, making them particularly effective in the face of chronic infections or cancer," said co-first author Gago da Graca.

The research also found that certain signals in the body could increase the number of ID3+ T cells, paving the way for improved treatments like CAR T cell therapy. While CAR T therapy has been transformative in treating certain cancers, its effectiveness can wane over time due to T cell exhaustion.

Professor Ricky Johnstone, Executive Director Cancer Research at Peter Mac and co-lead author of the study, said enhancing ID3 activity could strengthen the endurance of these cells, making therapies more effective and long-lasting.

"We discovered that ID3+ T cell formation could be promoted by specific inflammatory cues, potentially offering new strategies to boost the number of immune cells that excel at fighting cancer in patients," said Professor Johnstone.

"This could lead to better treatments for cancer patients and improve clinical immunotherapy outcomes."

The University of Melbourne's Dr Daniel Utzschneider, Laboratory Head at the Doherty Institute, said the findings could lead to advancements in immunotherapy treatments and the development of vaccines that provide long-lasting protection.

"Exhausted immune cells remain one of the biggest challenges in treating chronic diseases," said Dr Utzschneider.

"This research provides a roadmap for how we might reinvigorate the immune system to improve health outcomes for people living with cancer or chronic infections like HIV or hepatitis B and C, thanks to these stem-like T cells, the immune system's secret power."

This research is the result of a collaborative effort between the Doherty Institute, Peter Mac, La Trobe University, Northwestern University (USA), the Olivia Newton-John Cancer Research Institute, the University of Birmingham (UK) and the University of Melbourne.

January 29, 2025

Hidden Hunger Crisis: Alarming Study Reveals Half of Diabetics Are Missing Essential Nutrients

Hidden hunger affects nearly half of those with type 2 diabetes, with deficiencies in vital nutrients like vitamin D, magnesium, and B12 prevalent globally.

Micronutrient deficiencies, such as low vitamin D and magnesium, are alarmingly common in people with type 2 diabetes, affecting nearly half globally

Women and those in the Americas are at higher risk, and the study underscores the importance of addressing not just energy metabolism but also overall nutrition. Researchers call for targeted interventions and further studies to explore the causes and solutions to these deficiencies.

Micronutrient Deficiency in Type 2 Diabetes

Micronutrient deficiencies, where levels of essential vitamins and minerals are too low for proper bodily function, are commonly found in people with type 2 diabetes, according to a pooled data analysis published today (January 29) in the journal BMJ Nutrition, Prevention & Health.

The analysis highlights vitamin D as the most commonly deficient micronutrient, with women at greater risk than men. These deficiencies, often referred to as “hidden hunger,” pose a significant health challenge.

Researchers explain that type 2 diabetes is influenced by factors such as genetic predisposition, environmental conditions, sedentary lifestyles, unhealthy diets, and obesity. Previous studies suggest that micronutrients play a critical role in the disease’s development, potentially impacting glucose metabolism and insulin signaling pathways.

Exploring Global Data on Micronutrient Deficiencies

To estimate the global prevalence of micronutrient deficiencies in people with type 2 diabetes, researchers reviewed databases to identify relevant studies and pooled the available data for analysis.

The final analysis included 132 studies involving 52,501 participants, published in multiple languages between 1998 and 2023. Nearly all the studies (except for three) were conducted in hospital settings.

The analysis revealed that 45% of people with type 2 diabetes globally have micronutrient deficiencies (vitamins, minerals, and electrolytes), with the prevalence slightly lower (40%) among those with diabetes-related complications. Regional differences were attributed to varying dietary habits, lifestyle factors, and cultural practices.

Vitamin D deficiency was the most common, affecting 60.5% of individuals with type 2 diabetes. Magnesium deficiency was also widespread, affecting 42%, while iron deficiency impacted 28%. Vitamin B12 deficiency was reported in 29% of participants and was even more frequent among those taking metformin.

Regional and Gender Differences in Deficiency Rates

Further stratification of the pooled data showed that prevalence was higher in women with the condition than in men at nearly 49%, and highest among patients in the Americas (54%).

Most of the included studies were cross-sectional, making it difficult to establish causality, nor was it clear whether the micronutrient deficiency preceded poor glycaemic control or was a consequence of it, caution the researchers.

And as there are no valid population-based studies looking at micronutrient deficiency, it’s impossible to draw comparisons between patients with type 2 diabetes and the general population, they add.

Implications for Research and Policy

“This systematic review exemplifies the double burden of malnutrition in action, whereby nutritional deficiencies and diet-related non-communicable diseases, such as type 2 diabetes, co-exist,” comments Shane McAuliffe, Visiting Senior Academic Associate, NNEdPro Global Institute for Food, Nutrition and Health, which co-owns the journal.

“The treatment of type 2 diabetes often tends to focus on energy metabolism and macronutrients, but the identification of a higher prevalence of specific micronutrient deficiencies in those affected is a reminder that optimizing overall nutrition should always be a priority.

“The findings should help to focus research and policy initiatives aimed at furthering our understanding of the causes and effects of these deficiencies and the potential for targeted and tailored interventions.”

https://scitechdaily.com/hidden-hunger-crisis-alarming-study-reveals-half-of-diabetics-are-missing-essential-nutrients/